It mimics the hormone GLP-1, responsible for appetite regulation and hunger signals
We also educate thousands of public health leaders a year through our degree programs, postdoctoral training, fellowships, and continuing education courses
As the majority of patients with type 2 diabetes are overweight or obese this offers a potential advantage over older, established therapies, and DPP-4 inhibitors are being used in clinical practice as second-line therapy in addition to metformin in overweight and obese patients who fail to reach glycemic targets with metformin monotherapy
higher rates of nausea, vomiting, and discontinuation without meaningful long-term Starting to see how this market will evolve
MOTS-c has gradually been found to affect obesity, inflammation, neuroprotection, and aging-induced hypokinesia, potentially contributing to healthy aging